Geopolitical Tensions
May disrupt supply chains and increase costs.
- Materiality
- high
Orion Oyj
Orion is a Finnish pharmaceutical company that operates globally, focusing on the development, manufacturing, and marketing of human and animal medicines, as well as active pharmaceutical ingredients. The company is known for its wide range of original and generic medicines, as well as self-care products. Orion's core therapeutic areas include oncology and pain management. The company is listed on Nasdaq Helsinki and has a significant presence in the Nordic region.
8,8 %
19,9 %
−3,9 %
−3,8 %
1.03
0.59
| % | |
|---|---|
| Innovative Medicines | 30% Includes Orion's developed and marketed innovative drugs. |
| Branded Products | 20% Long-marketed branded pharmaceutical products. |
| Generics and Consumer Health | 25% Generic drugs and consumer health products. |
| Animal Health | 15% Pharmaceuticals for veterinary use. |
| Fermion | 10% Manufacture of active pharmaceutical ingredients for Orion and others. |
Orion serves a diverse range of customers including healthcare professionals, hospitals, pharmacies, and veterinary...
- Healthcare Professionalsprimary
Purchase innovative medicines for oncology and pain management.
- Pharmacies and Hospitalsprimary
Buy branded and generic pharmaceuticals for distribution.
- Veterinary Clinicssecondary
Use animal health products for treating pets and livestock.
- Pharmaceutical Companiessecondary
Source active pharmaceutical ingredients from Fermion.
Orion operates globally with a strong presence in the Nordic region, particularly Finland, which contributes...
- •Strong presence in the Nordic region, especially Finland.
- •Growing markets in Europe and North America.
- •Manufacturing facilities located in Finland.
- •Strategic geographic presence aids in leveraging regional market dynamics.
Orion's strategic priorities focus on expanding its innovative medicines portfolio, particularly in oncology and pain...
01
Expand Innovative Medicinesmedium-term
To drive growth in oncology and pain management.
02
Enhance Branded Productsmedium-term
To strengthen market position in Europe and Asia.
03
Data-Driven Operationslong-term
To improve decision-making and efficiency.
Orion faces several business and financial risks, including regulatory changes in the pharmaceutical industry and...
Regulatory Changes
Could affect product approvals and market access.
- Materiality
- high
Competitive Pressures
Could erode margins in the generics market.
- Materiality
- high
Currency Fluctuations
Impact financial performance due to international operations.
- Materiality
- medium
Revenue Recognition
Currency Translation
R&D Cost Estimates
Oriola Oyj
OKDAV.HE · Pharmaceutical Retailers
Oriola is a Nordic pharmaceutical company that operates in the distribution and wholesale of pharmaceuticals and health products across Finland and Sweden.
Orion S.A.
OEC · Miscellaneous Chemical Products
Terveystalo Oyj
TTALO.HE · Medical Care Facilities
Terveystalo is a Finnish healthcare service provider that operates through three main segments: Healthcare Services, Portfolio Businesses, and operations in Sweden.
Midsona A
MSON-B.ST · Consumer Staples
Midsona is a company focused on the production and distribution of organic and health food products across various European markets.
Oric Pharmaceuticals, Inc.
ORIC · Pharmaceutical Preparations
ORIC Pharmaceuticals is a U.S.-based clinical-stage biopharmaceutical company focused on discovering and developing cancer therapies designed to overcome treatment resistance.
Atria Oyj
ATRAV.HE · Packaged Foods
Atria is a leading Nordic food company specializing in the production and sale of fresh and processed meat products.
: 11/08/2026